FDA Eyes Manufacturing Innovation to Boost Drug Development

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-02-2004
Volume 28
Issue 5

New technologies, along with changes in FDA oversight, may provide a critical path to make more new drugs available more quickly to patients.

Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Roger Viney from ICE Pharma discusses the quality and compliance issues surrounding the use of animal-derived ingredients in the bio/pharma industry.